Filing Manager
Joe Lonsdale
Reporting Manager
8VC GP I, LLC
Symbol
SNTI
Shares outstanding
25,375,500 shares
Disclosed Ownership
253,755 shares
Ownership
1%
Form type
SCHEDULE 13G/A
Filing time
07 May 2025, 16:26:36 UTC
Date of event
31 Mar 2025

Quoteable Key Fact

"Joe Lonsdale disclosed 1% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 31 Mar 2025."

Quick Takeaways

  • Joe Lonsdale filed SCHEDULE 13G/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
  • Disclosed ownership: 1%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 07 May 2025, 16:26.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
8VC Fund I, L.P. 1% 249,827 0 249,827 /s/ Joe Lonsdale Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Fund I, L.P.
8VC Entrepreneurs Fund I, L.P. 0% 3,928 0 3,928 /s/ Joe Lonsdale Joe Lonsdale, Managing Member of 8VC GP I, LLC, the general partner of 8VC Entrepreneurs Fund I, L.P.
8VC GP I, LLC 1% 253,755 0 253,755 /s/ Joe Lonsdale Joe Lonsdale, Managing Member
Joe Lonsdale 1% 253,755 253,755 0 /s/ Joe Lonsdale Joe Lonsdale